Subscriber Login u: p:

Solbec's Coramsine wins tick from one US doctor
16-October-07
Written by Edited announcement

Osborne Park-based Solbec Pharmaceuticals Ltd has had a small win, with the United States Food and Drug Administration allowing the use of its Coramsine cancer treatment under a Physician's Investigational New Drug application.

The practice, similar to a compassionate use application under the Australian Therapeutic Goods Administration's Special Access Scheme, will allow one doctor to prescribe the medication to a patient after proving that the treatment had been effective.


Article continues...